Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,568 | -11,221 | -9,383 | -6,858 | -14 |
| Depreciation Amortization | 621 | 2,238 | 1,652 | 1,104 | 558 |
| Income taxes - deferred | N/A | N/A | -6,110 | -4,975 | -3,793 |
| Accounts receivable | 2,425 | -4,113 | -6,062 | -20,679 | -9,681 |
| Accounts payable and accrued liabilities | -1,409 | -334 | 542 | 3,091 | 3,470 |
| Other Working Capital | 2,820 | -68,684 | -60,646 | -65,865 | -59,177 |
| Other Operating Activity | -80 | 16,965 | 15,249 | 21,941 | 7,964 |
| Operating Cash Flow | $1,809 | $-65,149 | $-64,758 | $-72,241 | $-60,673 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -637 | -3,727 | -1,509 | -815 | -389 |
| Investing Cash Flow | $-637 | $-3,727 | $-1,509 | $-815 | $-389 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,022 | -409,724 | 10,426 | 8,258 | -412,082 |
| Common Stock Repurchased | N/A | N/A | -420,000 | -420,000 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -62 | 0 |
| Financing Cash Flow | $1,022 | $-409,724 | $-409,574 | $-411,804 | $-412,082 |
| Exchange Rate Effect | 319 | 1,372 | -322 | -31 | 90 |
| Beginning Cash Position | 237,366 | 714,594 | 714,594 | 714,594 | 714,594 |
| End Cash Position | 239,879 | 237,366 | 238,431 | 229,703 | 241,540 |
| Net Cash Flow | $2,513 | $-477,228 | $-476,163 | $-484,891 | $-473,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,809 | -65,149 | -64,758 | -72,241 | -60,673 |
| Capital Expenditure | -637 | -3,727 | -1,509 | -815 | -389 |
| Free Cash Flow | 1,172 | -68,876 | -66,267 | -73,056 | -61,062 |